IFM Investors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.7M Buy
304,017
+19,673
+7% +$2.11M 0.31% 59
2025
Q1
$28.7M Sell
284,344
-221
-0.1% -$22.3K 0.31% 62
2024
Q4
$25.4M Sell
284,565
-24,762
-8% -$2.21M 0.26% 70
2024
Q3
$25.9M Buy
309,327
+1,597
+0.5% +$134K 0.25% 75
2024
Q2
$23.7M Buy
307,730
+3,627
+1% +$279K 0.24% 82
2024
Q1
$20.8M Sell
304,103
-5,247
-2% -$359K 0.23% 86
2023
Q4
$17.9M Buy
309,350
+14,729
+5% +$852K 0.22% 94
2023
Q3
$15.6M Buy
294,621
+8,564
+3% +$452K 0.2% 96
2023
Q2
$15.5M Buy
286,057
+20,169
+8% +$1.09M 0.2% 96
2023
Q1
$13.3M Buy
265,888
+6,495
+3% +$325K 0.2% 101
2022
Q4
$12M Buy
259,393
+4,945
+2% +$229K 0.2% 107
2022
Q3
$9.86M Buy
254,448
+3,730
+1% +$144K 0.18% 117
2022
Q2
$9.34M Buy
250,718
+9,289
+4% +$346K 0.16% 129
2022
Q1
$10.7M Buy
241,429
+43,729
+22% +$1.94M 0.17% 120
2021
Q4
$8.4M Buy
197,700
+4,800
+2% +$204K 0.15% 130
2021
Q3
$8.37M Buy
192,900
+3,032
+2% +$132K 0.17% 113
2021
Q2
$8.12M Buy
189,868
+28,829
+18% +$1.23M 0.17% 128
2021
Q1
$6.22M Buy
161,039
+22,111
+16% +$855K 0.17% 125
2020
Q4
$4.99M Buy
138,928
+21,268
+18% +$765K 0.16% 131
2020
Q3
$4.5M Buy
117,660
+14,456
+14% +$552K 0.19% 112
2020
Q2
$3.62M Sell
103,204
-34,915
-25% -$1.23M 0.19% 116
2020
Q1
$4.37M Sell
138,119
-5,065
-4% -$160K 0.2% 114
2019
Q4
$6.48M Sell
143,184
-6,783
-5% -$307K 0.23% 94
2019
Q3
$6.1M Buy
149,967
+53,258
+55% +$2.17M 0.23% 95
2019
Q2
$4.16M Buy
96,709
+6,704
+7% +$288K 0.24% 89
2019
Q1
$3.45M Buy
90,005
+10,276
+13% +$394K 0.22% 96
2018
Q4
$2.82M Buy
79,729
+7,165
+10% +$253K 0.23% 95
2018
Q3
$2.79M Buy
72,564
+10,259
+16% +$395K 0.21% 105
2018
Q2
$2.04M Buy
62,305
+18,918
+44% +$619K 0.19% 115
2018
Q1
$1.19M Buy
43,387
+4,149
+11% +$113K 0.17% 142
2017
Q4
$973K Buy
39,238
+147
+0.4% +$3.65K 0.15% 154
2017
Q3
$1.14M Buy
39,091
+2,038
+6% +$59.4K 0.19% 121
2017
Q2
$1.03M Buy
37,053
+9,538
+35% +$264K 0.18% 129
2017
Q1
$684K Buy
27,515
+10,410
+61% +$259K 0.17% 139
2016
Q4
$370K Buy
+17,105
New +$370K 0.17% 153